Oliver P. Peoples - Jan 12, 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
President and CEO, Director
Signature
Charles B. Haaser, attorney-in-fact
Stock symbol
YTEN
Transactions as of
Jan 12, 2023
Transactions value $
$0
Form type
4
Date filed
1/13/2023, 03:23 PM
Previous filing
Aug 12, 2022
Next filing
Feb 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $0 +65K $0.00 65K Jan 12, 2023 Common Stock 65K $3.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options will vest and become exercisable in equal quarterly installments over 4 years from 1/12/2023, beginning on 4/12/2023 and ending on 1/12/2027.